Article on doctors’ concerns about Mexico’s recent approval of medical cannabis highlighted Medical Marijuana Inc.’s estimate on the size of the nation’s MMJ market
Mexico legalized medical cannabis in the first half of 2017 after extensive public debate over the efficacy of such legislation. Although seen as a victory by medical marijuana advocates, the Milenio article states that doctors and other health professionals still have concerns.
However, the concerns might not be what you’re thinking. Instead, the issues and questions center around establishing guidelines for production and distribution.
Advocates and health professionals such as neurologist Dr. Eduardo Barragan of the Children’s Hospital of Mexico are leading the push to have the Ministry of Health regulate how to produce and distribute medical marijuana. Such measures would result in lower costs and safer, more effective medical solutions.
With a doctor’s prescription, patients can now access products with non-psychoactive cannabidiol (CBD) but not those with even trace amounts of tetrahydrocannabinol (THC), as the Mexican government does not allow it.
As such, Medical Marijuana Inc. currently distributes CBD products in Mexico through its subsidiary HempMeds® Mexico. In fact, HempMeds® Mexico is the first company in the country to be approved for medical cannabis product importation into the country. As the article points out, it is estimated by Medical Marijuana Inc. that the medical marijuana market in Mexico, a country in the process of restructuring their cannabis policies, could be worth as much as $2.5 billion.
Yet, access to beneficial products is difficult, as the process for approval is often complex and time-consuming. Medical Marijuana, Inc. and HempMeds® Mexico are helping patients with this process so they can get approved more easily and quickly. Currently, the only legal product available in the country is RSHO-X™, a CBD oil with no detectable THC that HempMeds® Mexico produces and distributes. It is available as a prescription medication to patients in Mexico.
For more, you can read the article (in Spanish) here: